Recon: FDA advisers back Ardelyx kidney disease drug; UnitedHealth to offer Humira alongside biosimilars next year
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy